aid: armo-biosciences
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://kinlane-images.s3.amazonaws.com/shared/apis-json/icons/armo-biosciences.png
name: ARMO BioSciences *
description: 'ARMO BioSciences was a clinical-stage immuno-oncology biopharmaceutical company based in
  Redwood City, California, developing biologic therapeutics that activate a patient''s own immune system
  to fight cancer. Its lead candidate was pegilodecakin (AM0010), a PEGylated recombinant human interleukin-10
  (IL-10) evaluated across solid tumors. Backed by GV and Kleiner Perkins, the company IPO''d on NASDAQ
  in 2018 and was acquired by Eli Lilly and Company that same year for approximately $1.6 billion; its
  former web domain now redirects to lilly.com. As a life-sciences therapeutics developer it exposes no
  public developer API, SDK, or documentation surface. This profile is retained in the API Evangelist
  network as a portfolio/acquisition record rather than an active API provider.'
url: https://raw.githubusercontent.com/api-evangelist/armo-biosciences/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- gv
- kleiner-perkins
x-acquired-by: eli-lilly
x-acquired-year: '2018'
x-status: acquired
x-tier: stub
x-tier-reason: portfolio-lead
specificationVersion: '0.20'
created: '2026-07-17'
modified: '2026-07-18'
tags:
- Company
- Life Sciences
- Biotechnology
- Immuno-Oncology
- Pharmaceuticals
- Cancer
- Therapeutics
- Acquired
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
x-enrichment:
  date: '2026-07-19'
  status: backfilled
  pass: local-v1
  note: backfilled from .gitignore signal + verified work evidence